Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2015 08:00 ET | Source: CardioDx

Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer

REDWOOD CITY, CA--(Marketwired - Dec 14, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the appointment of Timothy Henn as Chief...
December 01, 2015 07:05 ET | Source: Myriad Genetics, Inc.

United States Patent and Trademark Office Grants Patent for Vectra(R) DA

SALT LAKE CITY, Dec. 1, 2015 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that the United States Patent and Trademark...
November 07, 2015 19:30 ET | Source: Myriad Genetics, Inc.

Crescendo Bioscience Announces That New Studies With Vectra(R) DA Data Will be Presented at the American College of Rheumatology 2015 Annual Meeting

SALT LAKE CITY, Nov. 7, 2015 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that new data on the use of Vectra DA to...
November 04, 2015 18:38 ET | Source: Lightbridge Corporation

Lightbridge Provides Update on Nuclear Fuel Commercialization Plan, Business Update and Selected Financial Results for the Third Quarter of 2015

MCLEAN, Va., Nov. 04, 2015 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR) today issued an update on its commercialization strategy and provided a business update for the three and nine...
November 02, 2015 16:30 ET | Source: Lightbridge Corporation

Lightbridge Schedules Third Quarter 2015 Earnings & Business Update Conference Call

MCLEAN, Va., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it will host a conference call on Thursday, November...
October 22, 2015 07:05 ET | Source: Myriad Genetics, Inc.

Crescendo Bioscience Highlights New Studies With Vectra(R) DA That Will Be Presented at the American College of Rheumatology 2015 Annual Meeting

SALT LAKE CITY, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that new data on Vectra DA will be presented...
October 19, 2015 07:30 ET | Source: Lightbridge Corporation

Lightbridge Announces Award of Export License for Planned Work in the Halden Research Reactor

Institute for Energy Technology Awarded Export License by the Norwegian Ministry of Foreign Affairs Export License Issued for Irradiation Testing and Discharge of Lightbridge-designed Metallic Fuel...
September 14, 2015 08:30 ET | Source: Lightbridge Corporation

Lightbridge and Canadian Nuclear Laboratories Sign Comprehensive Agreement for Fabrication of Lightbridge Nuclear Fuel Samples

MCLEAN, Va., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it has signed a Comprehensive Nuclear Services Agreement...
September 09, 2015 08:38 ET | Source: Transparency Market Research

Mice Model Market expected to reach USD 1.75 Billion by 2023: Transparency Market Research

Albany - NY, Sept. 9, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Transparency Market Research "Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and...
September 09, 2015 07:30 ET | Source: Lightbridge Corporation

Lightbridge Corporation to Present at the SeeThruEquity Fall Microcap Investor Conference in New York City

MCLEAN, Va., Sept. 09, 2015 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR) today announced that Seth Grae, President and CEO of Lightbridge will present at the SeeThruEquity Fall...